SCHEDULE: FMR LLC Discloses 5.5% Stake in Inflarx NV

FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 5.5% of Inflarx NV's common stock as of June 30, 2026.

Summary

• FMR LLC and Abigail P. Johnson, through FMR LLC, have filed a Schedule 13G, indicating beneficial ownership of 8,163,341 shares of Inflarx NV common stock.
• This holding represents 5.5% of the total outstanding common stock as of June 30, 2026.
• Fidelity Management & Research Company LLC is identified as an Investment Adviser (IA) and is the entity beneficially owning the shares.
• Abigail P. Johnson is the CEO of FMR LLC, and the Johnson family may be considered a controlling group of FMR LLC.
• The filing confirms that the shares were acquired and are held in the ordinary course of business and not for the purpose of influencing control of Inflarx NV.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, indicating a significant but stable institutional holding without immediate implications for control or strategy changes.

Positives

• Significant institutional ownership by FMR LLC, a reputable investment management firm, can lend stability and credibility to Inflarx NV.
• The filing indicates that the shares are held in the ordinary course of business, suggesting a long-term investment perspective rather than a short-term activist play.

Negatives

• The filing does not provide any specific financial performance data or strategic updates for Inflarx NV, limiting the insight into the company's operational health.

Risks

• While FMR LLC is a significant holder, the filing does not detail any specific risks related to Inflarx NV's business operations or market position.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding Inflarx NV's future performance.

Management Comments

• FMR LLC certifies that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.

Industry Context

StockSavvy.ai notes that the filing of a Schedule 13G by a major investment manager like FMR LLC is a common occurrence and typically signifies a passive investment stake, not an active attempt to gain control or influence company strategy.

Comparison to Industry Standards

• As a Schedule 13G filing, it adheres to standard SEC disclosure requirements for significant institutional investors holding less than 20% of a company's stock.
• The 5.5% ownership stake is a common threshold for institutional investors to report their holdings, aligning with typical investment patterns in the biotechnology or pharmaceutical sectors where Inflarx NV likely operates.

Stakeholder Impact

• Shareholders: The significant stake held by FMR LLC may be viewed positively, potentially indicating confidence in the company's long-term prospects, but the passive nature of the holding means no immediate strategic shift is implied.
• Management: The filing confirms that the investment is not intended to influence control, providing clarity on the nature of FMR LLC's relationship with Inflarx NV.

Next Steps

• FMR LLC will continue to hold its shares in Inflarx NV in the ordinary course of business.
• Further filings may be required if FMR LLC's ownership stake changes significantly.

Key Dates

Keywords

Inflarx NV, FMR LLC, Schedule 13G, Institutional Ownership, Beneficial Ownership, Common Stock, Investment Adviser